Analyst Rating In Review: Alnylam Pharmaceuticals Sold Off 0.1% Since Downgraded 7 Days Ago (ALNY)

One week ago Alnylam Pharmaceuticals (NASDAQ:ALNY) was downgraded from Outperform to Market Perform at Leerink. Alnylam Pharmaceuticals stocks closed at $36.17, a 0.1% loss over the course of one...